EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NONO Maintains SREBP ‐Regulated Cholesterol Biosynthesis via RNA Binding in Neuroblastoma

Song Zhang iD, Hayley Ingram iD, Jack Cooper iD, Alina Naveed iD, Stefan G Kathman iD, Garrett L Lindsey iD, Tao Liu iD, Charles S Bond iD, Jamie I Fletcher iD, Benjamin F Cravatt iD, Archa H Fox iD

The FASEB Journal · 30.09.2025 · 39 (18)

DOI: 10.1096/fj.202403267rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 16.09.2025. Verfasst von Song Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Human Sciences, The University of Western Australia, Crawley, Western Australia, Australia. Hauptthemen laut MEDLINE: Neuroblastoma, Cholesterol, RNA-Binding Proteins, Sterol Regulatory Element Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Government | DHAC | National Health and Medical Research Council (NHMRC), Australian Research Council Centre of Excellence in Advanced Molecular Imaging (Imaging CoE), National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐risk neuroblastoma is associated with upregulation of cholesterol biosynthesis through increased expression of sterol regulatory element—binding protein (SREBP). NONO, a multifunctional nuclear RNA binding protein, is an established oncogene in neuroblastoma and can stabilize SREBP in breast cancer. Hence, here we addressed the unexplored question of NONO regulation of SREBP in neuroblastoma. We show NONO knockdown reduces cholesterol in neuroblastoma patient‐derived tumor cell lines and high‐risk neuroblastoma KELLY cells. NONO knockdown also reduces mRNA and protein expression of SREBP family members in KELLY cells. RNA‐seq of NONO knockdown confirmed cholesterol synthesis pathway genes are downregulated. Further, only overexpression of NONO wild‐type, rather than NONO mutant lacking the RNA recognition motif 1, could elevate SREBP levels after endogenous NONO knockdown, revealing the importance of NONO RNA binding activity. Finally, (R)‐SKBG‐1, a small molecule that modulates the RNA binding activity of NONO, hence altering its subnuclear distribution, significantly decreased cholesterol levels and SREBP target gene expression in KELLY cells. These results lend weight to manipulating NONO RNA binding as a potential therapeutic avenue for treating aggressive neuroblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaCholesterolRNA-Binding ProteinsSterol Regulatory Element Binding ProteinsHumansCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

DBHSRNA bindingcholesterolexpressionneuroblastoma

Substanzen

CholesterolRNA-Binding ProteinsSterol Regulatory Element Binding Proteins

Autor:innen und Institutionen

  • School of Human Sciences, The University of Western Australia, Crawley, Western Australia, Australia.
  • Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
  • Children's Cancer Institute Australia, Randwick, New South Wales, Australia.
  • Centre for Childhood Cancer Research, UNSW Sydney, Kensington, New South Wales, Australia.
  • School of Molecular Sciences, The University of Western Australia, Crawley, Western Australia, Australia.
  • Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, New South Wales, Australia.

ORCID-Profile: Song Zhang, Hayley Ingram, Jack Cooper, Alina Naveed, Stefan G Kathman, Garrett L Lindsey, Tao Liu, Charles S Bond, Jamie I Fletcher, Benjamin F Cravatt, Archa H Fox

Förderung

  • Federal Government | DHAC | National Health and Medical Research Council (NHMRC)
  • Australian Research Council Centre of Excellence in Advanced Molecular Imaging (Imaging CoE)
  • National Health and Medical Research Council

Zitieren

APA

Zhang, S., Ingram, H., Cooper, J., Naveed, A., Kathman, S. G., Lindsey, G. L., Liu, T., Bond, C. S., Fletcher, J. I., Cravatt, B. F., & Fox, A. H. (2025). NONO Maintains SREBP ‐Regulated Cholesterol Biosynthesis via RNA Binding in Neuroblastoma. The FASEB Journal, 39(18). https://doi.org/10.1096/fj.202403267rr

Vancouver

Zhang S, Ingram H, Cooper J, Naveed A, Kathman SG, Lindsey GL, et al. NONO Maintains SREBP ‐Regulated Cholesterol Biosynthesis via RNA Binding in Neuroblastoma. The FASEB Journal. 2025;39(18). doi:10.1096/fj.202403267rr

BibTeX
@article{Zhang2025,
  author = {Zhang, Song and Ingram, Hayley and Cooper, Jack and Naveed, Alina and Kathman, Stefan G and Lindsey, Garrett L and Liu, Tao and Bond, Charles S and Fletcher, Jamie I and Cravatt, Benjamin F and Fox, Archa H},
  title = {NONO Maintains SREBP ‐Regulated Cholesterol Biosynthesis via RNA Binding in Neuroblastoma},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {18},
  doi = {10.1096/fj.202403267rr}
}
Kostenlos starten →